Loading clinical trials...
Loading clinical trials...
People with schizophrenia display a broad range of cognitive impairments that have been identified as major determinants of poor functioning and disability. Also, people with schizophrenia are at incr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NCT07419321 · Schizophrenia and Related Disorders
NCT05603104 · Schizophrenia and Related Disorders, Major Depressive Disorder, and more
NCT05671185 · Schizophrenia and Related Disorders
NCT07060066 · Schizophrenia and Related Disorders
NCT07119268 · Schizophrenia and Related Disorders, Sleep Disturbance
Stanford University
Stanford, California
Augusta University
Augusta, Georgia
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions